[-] Show simple item record

dc.contributor.authorDuke, Timeng
dc.contributor.authorMohundro, Brice L.eng
dc.date.issued2009-12eng
dc.description.abstractHigh-dose statins are better at prolonging the time to the first cardiovascular event in patients with diabetes and chronic kidney disease, but not in patients with diabetes who have normal kidney function. (SOR B, based on a randomized controlled trial.) High-dose statin therapy reduces the risk of myocardial infarction (MI) and stroke in patients with either acute coronary syndromes (ACS) or stable coronary artery disease (CAD), and has been demonstrated to reduce all-cause mortality in patients with ACS. (SOR A, based on a meta-analysis.)eng
dc.identifier.citationEvidence Based Practice 12(12): 07-08.eng
dc.identifier.urihttp://hdl.handle.net/10355/7665eng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofEvidence Based Practice 12(12): 07-08.eng
dc.relation.ispartofcollectionEvidence Based Practice, 2009eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. Evidence Based Practice.eng
dc.relation.ispartofseriesHelp Desk Answerseng
dc.subjectcardiovascular eventeng
dc.subjectlipoprotein concentrationeng
dc.subject.lcshLipoproteinseng
dc.subject.lcshNon-insulin-dependent diabeteseng
dc.subject.lcshCardiovascular emergencieseng
dc.titleWhat is the value of intensive statin therapy in lowering morbidity and mortality in patients at high risk for coronary artery disease?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record